Bacitracin

Drug ingredientActive Shortage

CAS 1405-87-4

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

US productionNot reported

Import value, 2024$546M

Top sourceItaly 41%

This chemical is listed as active in US commerce, but no company reported it to EPA’s survey for 2019 or 2023. Sites may have made or imported less than the threshold amount, or none.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 294190 · basket

These shares come from HS customs code 294190, which covers 90 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

IT 41%ItalyCN 24%ChinaDK 9%DenmarkHR 6%CroatiaIN 6%India

United Kingdom
Slovakia
Slovenia
Mexico
Canada
Germany
Belgium
Japan
Switzerland
Netherlands
Czech Republic
Uruguay
South Korea
Hong Kong
Portugal
Australia

33 FDA-registered drug labelers

A-S Medication Solutions

AlderMed Inc.

ALLIED TRADE LINK LLC

BluePoint Laboratories

Bryant Ranch Prepack

Cosette Pharmaceuticals, Inc.

CVS Pharmacy

Dolgencorp, LLC

Dollar General

Dynarex Corporation

H E B

Josun International Limited

Joyang Laboratories

Kroger

Kroger Company

Lifecome Biochemistry Co., Ltd

Major Pharmaceuticals

Medisca Inc.

Meijer Distribution Inc

North China Pharmaceutical Huasheng Co. Ltd.

NuCare Pharmaceuticals,Inc.

O&M HALYARD, INC.

Padagis Israel Pharmaceuticals Ltd

Preferred Pharmaceuticals Inc.

Proficient Rx LP

RUGBY LABORATORIES

Safeway

Topco Associates LLC

Trifecta Pharmaceutical USA LLC

Trifecta Pharmaceuticals USA

Vive Health LLC

Xellia (Taizhou) Pharmaceuticals Co., Ltd

Zapatol Corp.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 10 drug and cosmetic product listings (FDA).

•Bacitracin
•MediChoice Triple Antibiotic
•Rexall Antibiotic
•signature care first aid antibiotic
•Zapotol Bacitracin
•Antibiotic
•Triple Antibiotic
•Major Bacitracin

Show all 10

•DG Poly Antibiotic First Aid Antibiotic
•MediChoice Bacitracin

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

Active Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

Current shortage
Bacitracin Ophthalmic Ointment
Shortage listed since March 3, 2025
Manufacturer reports: 1 unavailable

See all current drug shortages

Chemical Identity

CAS1405-87-4

PubChem CID10909430

DTXSIDDTXSID8045355

FormulaC66H103N17O16S

Mol. Weight1422.7 g/mol

SMILESCCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4

Data Sources

PubChem · compound 10909430Retrieved 2026-04-07
EPA TSCA InventoryRetrieved 2026-04-24
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Bacitracin (CAS 1405-87-4) https://chemicalindependence.com/chemical/1405-87-4/ PubChem: 10909430. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/10909430 EPA TSCA Inventory: CAS 1405-87-4. Retrieved 2026-04-24. https://www.epa.gov/tsca-inventory FDA Drug Shortages: CAS 1405-87-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 294190 for CAS 1405-87-4. Reporting year: 2024. https://usatrade.census.gov/